See the DrugPatentWatch profile for Zostavax
Is Zostavax actually discontinued in 2026?
Zostavax (the live zoster vaccine) has been discontinued in the sense that it is no longer being supplied for routine use in the US. The product’s market withdrawal took place earlier than 2026 (the US moved to Shingrix for zoster prevention, and Zostavax availability dwindled accordingly). That means a “2026 discontinuation” would not reflect a new change so much as the continuing effect of earlier pullback/discontinuation.
What should people do if they were expecting Zostavax in 2026?
If you’re looking for protection against shingles in 2026, the expected substitute is Shingrix, which is the non-live recombinant zoster vaccine used for adults at risk. Shingrix is the standard choice because it replaced Zostavax for routine prevention.
Does discontinuation mean Zostavax no longer works or can’t be used?
Discontinuation relates to supply/marketing status, not to the biology of the vaccine. If someone already received Zostavax in the past, they don’t need to “revoke” that dose. For people who have not been vaccinated, guidance in practice shifts toward the currently supplied vaccine (Shingrix) rather than trying to obtain Zostavax.
Why was Zostavax replaced?
The switch from Zostavax to Shingrix happened because Shingrix provides stronger, more durable protection and is not a live vaccine. That made it the preferred option as health systems updated recommendations and purchasing/stock moved to Shingrix.
Are there any exceptions (research use, leftover stock, other countries)?
Availability can vary by country and by what individual providers have on hand. In places where Zostavax was already withdrawn, it generally won’t be newly ordered in 2026. Some regions may have limited leftover inventory for a time, but that’s not the same as a new ongoing supply.
If someone already got Zostavax, should they still get Shingrix?
This depends on the person’s age, immune status, and timing since the Zostavax dose. Many clinical guidance pathways support vaccination with Shingrix even after prior Zostavax, but the exact recommendation depends on patient factors and local guideline wording.
What to check right now for the most accurate 2026 status
Because “discontinued status 2026” can mean different things (US availability vs. worldwide vs. package-level label status), the safest checks are:
- Your country’s regulator and vaccine registry updates
- Your clinic/pharmacy’s current ordering status
- Your local immunization schedule for shingles (what vaccine is recommended and available)
If you tell me your country (and whether you mean the US or another market), I can narrow the answer to the relevant 2026 status and what vaccine is recommended there.